STOCK TITAN

Perrigo Co Plc SEC Filings

PRGO NYSE

Welcome to our dedicated page for Perrigo Co Plc SEC filings (Ticker: PRGO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking Perrigo’s global self-care operations means sorting through FDA correspondence, European labelling rules, and dozens of product-recall footnotes scattered across hundreds of pages. Whether you’re checking how inflation squeezed infant-formula margins or comparing store-brand versus branded revenue, the raw SEC data can feel overwhelming.

Stock Titan distills every Perrigo annual report 10-K simplified, each Perrigo quarterly earnings report 10-Q filing, and any Perrigo 8-K material events explained into concise, plain-English highlights. Our AI maps line items to the questions professionals actually ask—“What did Perrigo spend on quality remediation?” or “How did international currency swings hit EPS?”—and flags risk language automatically. Receive Perrigo Form 4 insider transactions real-time, monitor Perrigo executive stock transactions Form 4, and review the Perrigo proxy statement executive compensation without manual searches. For professionals intent on understanding Perrigo SEC documents with AI, our platform layers contextual definitions over GAAP terms and links directly to source exhibits.

Looking for Perrigo insider trading Form 4 transactions ahead of a product launch? Need a quick Perrigo earnings report filing analysis that separates North American from international self-care trends? Or simply want Perrigo SEC filings explained simply so you can brief clients in minutes? Every document arrives within seconds of hitting EDGAR, paired with AI-powered summaries, key-metric tables, and historical comparisons. Spend more time assessing how Perrigo’s affordable OTC strategy drives cash flow and less time sifting through PDFs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Perrigo Company plc (PRGO) insider purchase disclosed on 08/22/2025. Robert Willis, EVP & CHRO and an officer of the company, purchased 1,488 ordinary shares in open-market transactions at a weighted average price of $24.098 per share (individual trade prices ranged from $24.06 to $24.18). After the purchases, Mr. Willis beneficially owns 41,939 shares. The filing was executed by an attorney-in-fact and includes an undertaking to provide details of the number of shares bought at each price upon request. No derivative transactions or other changes in ownership were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Perrigo Company plc (PRGO) Form 4/A corrects an earlier filing to show that on 08/18/2025 the reporting person, Geoffrey M. Parker, had 4,375 ordinary shares acquired at a price of $22.9708, and those shares were acquired indirectly by the Geoffrey M. Parker Roth IRA rather than directly. After this transaction the Roth IRA held 9,875 shares. The filing also lists other holdings: 28,912 ordinary shares disposed (as reported) and 25,879 ordinary shares held indirectly via a revocable trust in which Geoffrey and Jill Parker are trustees. The amendment states the only change from the original Form 4 is correcting the manner of acquisition to reflect the IRA ownership. The form is signed by an attorney-in-fact for Mr. Parker on 08/19/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
insider
Rhea-AI Summary

Geoffrey M. Parker, a director of Perrigo Company plc (PRGO), purchased 4,375 ordinary shares on 08/18/2025 at $22.9708 per share. Following the purchase, Mr. Parker is reported to beneficially own 33,287 shares directly and holds additional indirect holdings of 25,879 shares through a revocable trust and 5,500 shares in a Roth IRA, as disclosed on Form 4. The filing was signed by an attorney-in-fact on 08/19/2025 and includes explanatory notes identifying the trust and the Roth IRA as the vehicles for indirect ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Perrigo Company plc insider filing shows EVP & Chief Financial Officer Eduardo Bezerra purchased 3,000 ordinary shares on 08/18/2025 at a reported price of $22.7356 per share, increasing his beneficial holdings to 48,949 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing contains no additional transactions or derivative activity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

State Street Corporation reported beneficial ownership of 7,340,323 shares of Perrigo Co plc common stock, representing 5.3% of the class. The filing is a Schedule 13G and shows shared voting power of 6,531,899 and shared dispositive power of 7,340,323, with no sole voting or dispositive power reported. The submission names multiple State Street advisory subsidiaries as related entities and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Form 4 summary: Reporting person Patrick Lockwood-Taylor (Director; CEO) filed a Form 4 for PERRIGO Co plc (PRGO) reporting purchases on 08/08/2025.

Transactions: Ordinary shares acquired: 4,060 at $22.3682 (beneficial ownership after: 85,412); 346 at $22.38 (85,758); 54 at $22.37 (85,812). The form is signed by attorney-in-fact Diana Witt on 08/08/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Perrigo Company plc — Quarterly highlights (Q2 ended June 28, 2025)

Net sales of $1,056.3M for the quarter and $2,100.2M for six months, down vs. prior year. Gross profit for the quarter was $362.9M. Operating income improved to $45.4M (vs. a loss of $26.5M a year ago); continuing operations reported a small loss of $0.5M for the quarter. Discontinued operations produced a loss of $7.9M, and diluted EPS was a loss of $0.06 for the quarter and $0.10 for six months.

Balance sheet and cash: cash and equivalents $454.2M (down $104.6M YTD); inventories increased to $1,215.5M. Total assets $10,094.1M; total liabilities $5,621.8M. Total borrowings outstanding $3,651.9M. Notable items: sale of Richard Bittner Business for $14.4M (pre-tax loss $1.6M); Prevacid impairment $1.5M; litigation accrual for price-fixing $30.0M with a 50% recovery receivable under indemnity (Altaris cap $50.0M). Foreign currency translation increased comprehensive income, producing comprehensive income of $137.0M for the quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.31%
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.31%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Perrigo Co Plc (PRGO)?

The current stock price of Perrigo Co Plc (PRGO) is $23.76 as of August 28, 2025.

What is the market cap of Perrigo Co Plc (PRGO)?

The market cap of Perrigo Co Plc (PRGO) is approximately 3.3B.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Stock Data

3.26B
136.97M
0.4%
105.75%
4.14%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2